Cobalt Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Gemphire Announces Top-Line Data from COBALT-1 Phase 2b Clinical Trial in HoFH Patients
LIVONIA, Mich., June 28, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) today announced top-line data on the LDL-C primary endpoint from the completed open label Phase 2b COBALT-1 trial. COBALT-1 evaluated gemcabene in homozygous... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - June 28, 2017 Category: Pharmaceuticals Source Type: clinical trials

90‐Day Cobalt Supplementation Study to Investigate the Cobalt Body Burden in Ten Healthy Adult Volunteers
Conditions: Cobalt Biokinetics; Safety of Cobalt Dietary SupplementationIntervention: Sponsors: Cardno ChemRisk; DePuy OrthopaedicsCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2013 Category: Research Source Type: clinical trials